Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2019-03-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
第三届监事会第十五次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 15th meeting of the third Supervisory Board of Ruikang Medical Group Co., Ltd. It includes voting results and mentions that the proposals will be submitted to the 2019 second extraordinary general meeting of shareholders for approval. The content focuses on internal supervisory board decisions and related announcements, not a full report or financial statement. The document length is short (1166 characters) and it is an official announcement of board/management decisions rather than a detailed report or financial filing. Therefore, it fits best under Board/Management Information (MANG).
2019-03-20 Chinese
第三届董事会第十九次会议决议的公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at the 19th meeting of the 3rd Board of Directors of Ruikang Medical Group Co., Ltd. It details board decisions on guarantees for subsidiaries, changes in fundraising investment projects, adjustments to share repurchase matters, and the scheduling of a shareholders' meeting. The document includes voting results and references to related announcements and independent opinions published elsewhere. It is not a full report but a formal announcement of board meeting decisions and resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2019-03-20 Chinese
关于2018年第一期员工持股计划的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's 2018 first employee stock ownership plan. It includes details about stock purchases under the plan, transaction amounts, and compliance with disclosure regulations. The document is relatively short (1226 characters) and focuses on an update about capital/financing activities related to employee stock ownership. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The content fits best under Capital/Financing Update (CAP) as it reports on financing activities related to employee stock plans.
2019-03-05 Chinese
关于股份回购的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It references previous approvals and disclosures about the share buyback but primarily provides an update on the status of the repurchase account and the company's intention to continue the plan. The document length is short (860 characters), and it does not contain financial statements or detailed financial data. It is not a full report but an announcement about the progress of a share repurchase. Therefore, it fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2019-03-05 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2018 年度业绩快报' which translates to '2018 Annual Performance Express Report' or '2018 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2018, including revenue, profit, net income, earnings per share, and explanations of performance and financial condition. The document explicitly states that the data is preliminary, internally audited but not audited by an accounting firm, and may differ from the final annual report. It also discusses reasons for changes in financial results and compares with previous forecasts. The length is 1947 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a certification. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights. It is not a full Annual Report (10-K) because it is preliminary and not audited externally, and it is not a Report Publication Announcement (RPA) because it contains actual financial data, not just a notice of report availability. Therefore, the best classification is Earnings Release (ER). FY 2018
2019-02-28 Chinese
关于公司董事、高管和核心骨干成员增持公司股份计划完成的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding increase plan by the company's directors, senior management, and key personnel. It details the number of shares increased, the timing, and compliance with relevant laws and regulations. There is no financial report, earnings data, or management discussion of financial results. The content focuses on insider share transactions by company executives. Therefore, this document fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2019-02-12 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.